CRVSCorvus Pharmaceuticals, Inc.
$10.51+37% 1Y
$10.51
$6.5052 weeks$25.52
Is the business good?
How good a business is CRVS?
- Share count, year on year
- +19%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$45M
- Net income, trailing twelve months
- −$54M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks
Biotechnology
Ranks #193 of 194 by RyuScore